about
Luteinizing hormone elevation in ovarian granulosa cell tumor: a case report and review of the literatureEffects of fifth day (D5) or sixth day (D6) frozen-thawed blastocysts on neonatal outcomes.An update on the progress of transcriptomic profiles of human endometrial receptivity.Traditional Chinese medicine: perspectives on and treatment of menopausal symptoms.Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city.Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study.Primary osteoporosis in postmenopausal women.Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study.Optimizing quality of life in perimenopause: lessons from the EastDienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension StudyEvidence that growth hormone can improve mitochondrial function in oocytes from aged micePrevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled studyEfficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical TrialChinese women with 29-30 FMR1 CGG repeats have an earlier menopauseEndometriosis-related ceRNA network to identify predictive biomarkers of endometrial receptivityOvarian reserve evaluation in a woman with 45,X/47,XXX mosaicism: A case report and a review of literatureManagement of precocious puberty in girls with McCune-Albright syndrome using letrozoleAttitude and knowledge for menopause management among health professionals in mainland China
P50
Q39259162-89D2C939-6523-4893-B019-9FAFD9A7A87FQ39430002-56240281-8AC8-450A-B3B8-1EFB46CAFB46Q47714562-B65EF1F3-3CF7-467E-A469-2B1B942821A0Q50119425-60E1EEBC-69CE-4857-9FFA-C149288B42D6Q50771697-9B7EB370-29BB-4F31-A602-7127F6428003Q51792303-0FAD6D77-F08E-432E-AFA7-CEEC105807E3Q55012766-789EBA33-A10A-42F7-B913-481C7E4EF8F6Q55331272-9AB356E5-8FD7-4EC9-A9C8-D64FF979D0ADQ58578036-8CF1C464-948B-40CC-BD7D-F98BDF7C19EFQ64120913-095A2C66-F5A8-417F-9C59-4C946833E9CAQ64267347-76436AF3-3370-420F-B058-E4BBD6D8D6CFQ88106090-715AF12E-30D4-49C8-88B5-4EC9F9BDA929Q89343097-E342D268-A404-48EB-917F-88EB7ABE7733Q89929553-CC3A4B5D-0E6E-483D-B1B6-3CC0E8C6C4B1Q91024304-7A48CBF7-1677-4195-B6E2-C4D0744A9FAEQ91875034-A5999A00-7418-46CF-9F09-4C11D7A32103Q93365355-07DF7D68-6E75-4C0A-874B-92F2C2EB17A1Q96434991-6C6B621A-3E6B-405D-BC56-38E87AF78C18
P50
description
researcher (ORCID 0000-0001-9737-5957)
@en
name
Qi Yu
@en
Qi Yu
@nl
type
label
Qi Yu
@en
Qi Yu
@nl
prefLabel
Qi Yu
@en
Qi Yu
@nl
P31
P496
0000-0001-9737-5957